Novavax Enters into Significant Licensing Agreement with Pfizer
Shares of the American biotechnology company Novavax rose 9% to $8.72 as of January 20. This increas...
Ipsen's IPN60340 Receives FDA Breakthrough Therapy Designation for Acute Myeloid Leukemia
The U.S. Food and Drug Administration (FDA) recently granted Breakthrough Therapy Designation (BTD) ...
ImmunityBio Receives Saudi Approval for Anktiva's New Therapy in Lung Cancer Treatment
New developments have emerged from the American immunotherapy company ImmunityBio. The Saudi Food an...
GSK and Noetik Partner to Accelerate Oncology Drug Development
Artificial intelligence-based biotechnology company Noetik announced a five-year strategic collabora...
Johnson & Johnson Reaches Agreement with U.S. Government on Drug Price Cuts in Exchange for Tariff Exemptions
On January 8, Johnson & Johnson announced that it had reached an agreement with the Trump administra...
U.S. Food and Drug Administration (FDA) Approves Omeros' New Drug Yartemlea for the Treatment of Transplant Complication TA-TMA
Wedoany.com Report-Dec.31, The U.S. Food and Drug Administration (FDA) has officially approved Yarte...
Mabwell's Adalimumab Injection Approved for Marketing in Indonesia
Wedoany.com Report-Dec.31, Mabwell (688062.SH), an innovative biopharmaceutical company with a full ...
Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
Wedoany.com Report-Dec.30, Osaikang announced that its subsidiary Jiangsu Osaikang Pharmaceutical Co...
Ipsen Outlays $1BN for China-Based Simcere’s Preclinical ADC
Wedoany.com Report-Dec.28, Ipsen has entered into an exclusive licensing agreement with Simcere Zaim...
China’s Jacobio Inks Immuno-Oncology Deal Worth $1.9 B With AstraZeneca
Wedoany.com Report-Dec.26, China-based Jacobio Pharma (1167.HK) has entered into a global exclusive ...